SP4 is a sequence-specific DNA-binding transcription factor that recognizes GT and GC box promoter elements and acts as a transcriptional regulator of RNA polymerase II-dependent genes 1. SP4 functions as a transcriptional hub regulating multiple target genes across diverse biological processes. In pain signaling, SP4 recruits to TRPV1 and TRPA1 gene promoters following nerve growth factor stimulation, driving upregulation of these nociceptive ion channels and contributing to the transition from acute to chr7 pain through repeated cycles of TRP channel overexpression 2. SP4 also regulates tumor-associated genes; it directly activates PTTG1IP gene transcription, a proto-oncogene implicated in pituitary, thyroid, and breast cancer development 3. In cancer biology, SP4 functions as a non-oncogene addicted factor—silencing SP4 independently decreases cancer cell growth, invasion, and induces apoptosis without compensatory upregulation by related Sp factors 4. Genetically, SP4 polymorphisms associate with altered gastric cancer susceptibility in age- and lifestyle-dependent patterns 5. SP4 is also validated as a schizophrenia-risk gene with truncating mutations conferring high odds ratios; GC-box containing genes are significantly over-represented among schizophrenia-risk loci, suggesting SP4 coordinates a regulatory network in neuropsychiatric disease 1. These findings establish SP4 as a pleiotropic transcription factor with critical roles in pain transduction, oncogenesis, and psychiatric disease pathogenesis.